Barry J. Schindler is the Co-Chair of Greenberg Traurig's Global Patent Prosecution Group -- a group of approximately 4,000 domestic and 4,100 foreign applications pending and over 100 attorneys, who are registered with the USPTO. Barry has more than twenty-five years of legal experience in all aspects of pharmaceutical and chemical patent prosecution -- representing numerous major pharmaceutical and chemical companies regarding patents relating to small molecules and synthetic compounds.

Barry has helped companies of all sizes build and manage significant patent portfolios, develop in-house procedures, and formulate intellectual property strategies. Barry positions clients to gain a competitive advantage by identifying patentable subject matter and drafting claims and providing patent opinions in such a way that infringement becomes possible to prove. Barry, an active member of the firm's Israel Practice also focuses his practice on managing the patent portfolio for numerous innovative Israeli start-ups. Barry is a frequent business visitor to Israel and is very involved with the local tech community.

Concentrations

• Legal Areas

  • Patent Portfolio Management

  • Business Methodology

  • Patent Litigation

  • Prosecution of Patent Applications

  • Reexaminations and IPR Proceedings

• Technical Areas

  • Chemical Compounds and Processes: Metallurgy; Medical Devices; Food Products/Supplements; Plastics; Material Science

  • Industrial Controls: Software; Mechanical and Electrical Devices; Internet Based Systems and Methods; Search Engine Technology; Database Management

  • Financial Derivatives and Systems: Exotic Financial Derivatives

  • Telemedicine

  • Internet-based Systems

  • Plastics

  • Agriculture